When the disease knocks, along with the worry of treatment, the prices of the medicine also become a burden on the pocket. Especially in the treatment of serious diseases like cancer, diabetes or life-threatening infection, medicines become out of the reach of the common man. But now the central government has taken an important decision which will give great relief to the patients. The government has decided to fix the price of 71 medicines. This includes major medicines used in diseases like cancer, diabetes and infection.
Let us tell you, medicines for metastatic breast cancer, allergy, diabetes and other serious diseases are now going to be available to you at a cheaper rate. According to the notification issued by the National Pharmaceutical Pricing Authority (NPPA), now GST can be added only in the case when it has been paid to the government. These medicines include reliance Life Sciences' 'Trastuzumab', which is used in the treatment of metastatic breast cancer and gastric cancer. Its price has now been fixed at ₹ 11,966 per vial. What is the price of the rest of the medicines
Apart from this, the price of Ceftriaxone, Disodium Edetate and Sulbactam Powder used in the treatment of life-threatening infections has been fixed at Rs 626, while the price of Combipack has been fixed at Rs 515. NPPA has also notified the price of 25 anti-diabetic formulations in its new notification, which include Sitagliptin as the main ingredient. Apart from this, many other diabetes medicines with empagliflozin combination are also included in this list.
Government in the direction of bringing transparency
This step is being taken to provide relief to patients from expensive medicines as well as to bring transparency. Some time ago, NPPA had issued an order saying that all drug manufacturers should send the list of prices of their products to dealers, state drug controllers and the government and mention that this price has been fixed or revised under any notification or order of the government.
This decision is not only a big relief for patients from the economically weaker sections, but will also promote transparency and accountability in the pharmaceutical industry. Now people will have the right to know while purchasing medicines whether those medicines are available at a fair and prescribed price. This step of the government is a positive effort towards the right to health.
click and follow Indiaherald WhatsApp channel